SCHEMBL23309718

SCHEMBL23309718

CC(C)(C)NC(=O)c1cc(F)nc(F)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.49
▸ APEX1 P27695 1/20 0.49
▸ MAOA P21397 2/20 0.39
▸ MAOB P27338 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GLA P06280 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ AR P10275 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ALOX5AP P20292 2/20 0.36
▸ FEN1 P39748 2/20 0.36
▸ SYK P43405 1/20 0.36
▸ ALPL P05186 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309725 0.81 GAA (0.43) MAOAMAOBALDH1A1GAAHPGD
SCHEMBL23309530 0.77 KLKB1 (0.39) HPGDLMNAKMT2A
SCHEMBL23309640 0.77 DHODH (0.39) —
SCHEMBL23309580 0.77 KLKB1 (0.41) MAOAMAOBALDH1A1SMN1; SMN2GAA
SCHEMBL23309632 0.76 KDM4E (0.36) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL23309599 0.75 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL23309730 0.75 KMT2A (0.47) MAOAMAOBKDM4EALDH1A1SMN1; SMN2
SCHEMBL23309637 0.74 POLB (0.44) POLBKDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL23309619 0.74 NPC1 (0.40) KDM4EALDH1A1SMN1; SMN2GLAGAA
SCHEMBL3387152 0.72 KEAP1 (0.42) KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL POLB 1411/4885APEX1 2956/4885MAOA 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback